Tuesday, May 9, 2017

Why Shares of Biopharma Giant Celgene (CELG) Tumbled Today

http://ift.tt/2pYjcTE

Why Shares of Biopharma Giant Celgene (CELG) Tumbled TodayOn Monday, shares of biopharmaceutical company Celgene Corp. (CELG) tumbled, and closed the day down 3.31% to $118.36 per share after one of its partners, Acceleron Pharma (XLRN), reported disappointing first-quarter results. XLRN stock closed down 12.79% to $27.69 per share.

May 09, 2017 at 05:44AM

http://ift.tt/2peKcPi

from

http://ift.tt/2peKcPi


at

No comments:

Post a Comment